The first stop for professional medicines advice

Guidance

663 results

Applied filters

Using clopidogrel with proton pump inhibitors (PPIs)

22 May 2023Avoid the combined use of clopidogrel with omeprazole or esomeprazole due to a significant interaction. Other PPIs are considered safe with clopidogrel.

Using angiotensin-II receptor antagonists during breastfeeding

11 May 2023Very limited data suggest breastmilk levels are likely to be low, but other medicine classes are preferred. Recommendations apply to full term, healthy infants.

Understanding Patient Group Directions and Integrated Care Boards

3 May 2023We outline the responsibilities of ICBs in England as commissioners of NHS services using PGDs, and link to resources that provide further support and advice.

Trimethoprim for Urinary Tract Infection (UTI)

25 April 2023SPS PGD template for the supply of trimethoprim tablets for the treatment of Urinary Tract Infection (UTI).

Nitrofurantoin for Urinary Tract Infection (UTI)

25 April 2023SPS PGD template for the supply of nitrofurantoin capsules/tablets for the treatment of Urinary Tract Infection (UTI).

Using lipid-lowering medicines during breastfeeding

21 April 2023Rosuvastatin, pravastatin and atorvastatin are preferred; simvastatin and ezetimibe can also be used. Recommendations apply to full term and healthy infants.

Omeprazole for use within antenatal and maternity services

20 April 2023SPS protocol templates for the supply and administration of omeprazole for pre planned caesarean section by registered midwives.

Legal provision of GSL and P medicines by registered midwives

20 April 2023Advice to support registered midwives in the legal administration and/or supply of P and GSL medicine, using omeprazole tablets as an example.

Submitting iQAAPS Quality Indicators (QIs)

13 April 2023Guidance for Accountable Pharmacists on submission of Quality Indicators (QI) for NHS Section 10 aseptic preparation activities using the iQAAPS system.

Using bisphosphonates with proton pump inhibitors (PPIs)

4 April 2023Although no interaction between bisphosphonates and PPIs is documented, the increased risk of fractures when given together should be reviewed and managed
admin